Cargando…
Harnessing the Nucleolar DNA Damage Response in Cancer Therapy
The nucleoli are subdomains of the nucleus that form around actively transcribed ribosomal RNA (rRNA) genes. They serve as the site of rRNA synthesis and processing, and ribosome assembly. There are 400–600 copies of rRNA genes (rDNA) in human cells and their highly repetitive and transcribed nature...
Autores principales: | Xuan, Jiachen, Gitareja, Kezia, Brajanovski, Natalie, Sanij, Elaine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393943/ https://www.ncbi.nlm.nih.gov/pubmed/34440328 http://dx.doi.org/10.3390/genes12081156 |
Ejemplares similares
-
Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy
por: Kang, Jian, et al.
Publicado: (2021) -
The RNA polymerase I transcription inhibitor CX-5461 cooperates with topoisomerase 1 inhibition by enhancing the DNA damage response in homologous recombination-proficient high-grade serous ovarian cancer
por: Yan, Shunfei, et al.
Publicado: (2020) -
Treacle Sticks the Nucleolar Responses to DNA Damage Together
por: Gál, Zita, et al.
Publicado: (2022) -
CX-5461 can destabilize replication forks in PARP inhibitor-resistant models of ovarian cancer
por: Xuan, Jiachen, et al.
Publicado: (2020) -
CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer
por: Sanij, Elaine, et al.
Publicado: (2020)